TABLE I

Expression of T Cell Antigens on NKH l a + Cells in Normal Peripheral Blood
* Number of cells expressing both cell surface antigens was determined by direct immunofluorescence and simultaneous two-color analysis using an EPICS V. 10,000 cells were analyzed in each experiment and results are expressed as percent of total PBMC and as a percent of the number of NKH1 + cells.
laser exciting both FITC and PE at 488 nm using an Epics V (Coulter Electronics, Hialeah, FL). Electronic compensation for the small overlaps of green and red fluorescence yield signals essentially identical to those with either reagent alone. 10,000 cells were analyzed in each sample and results displayed as an orthographic projection plotting log green versus log red fluorescence. In the sorting experiments, NKH 1 +T3 + doubly fluorescent cells were separated from NKH 1 +T3-(green only) and from NKH l-T3 + (red only) cells. The purified cells were sorted in RPMI 1640 plus 10% pooled human AB serum at a rate of 3,000 cells/s. Cells were then washed twice and resuspended in RPMI 1640 containing 5% AB serum for functional assays and cytocentrifuge smears. Cytotoxicity Assays. Cytotoxicity assays were performed using a standard chromium release method previously described (3). In the blocking studies with anti-T3, purified effector cells were cultured overnight at 37°C after cell sorting in the presence of anti-T3 or control antibody (anti-NKH 1A). Subsequently, mAbs were also added to individual wells for the 4 h cytotoxicity assay. Culture of Cell Sorter-pur~ed Subpopulations. NKH 1A+T3 + cells purified by cell sorting were cultured on a feeder layer of irradiated (5,000 rad) allogeneic PBMC plus EBVtransformed B cells and 10% lymphocyte-conditioned medium. After 10-14 d, the polyclonal cell lines contained 60-80% T3+NKH I + cells. These cells were then resorted as described above, to obtain a population that was >95% T3+NKH1 +. Resorted cells were then used for cytotoxicity assays without further in vitro culture.
Results
Two-Color Analysis of Peripheral Blood Lymphocytes.
In order to evaluate the coexpression of NKH 1 and T cell antigens, PBMC from six different individuals were examined (Table I ). The mean percent of NKH l+T3 + cells in peripheral blood was 2.5% of PBMC. This represents ~24% of the NKH1 ÷ population. The T4 antigen is very rarely coexpressed with NKH 1 and <1% of total PBMC express this phenotype. NKHI+T8 + cells compose ~2.6% of total PBMC and this represents 26.3% of all NKH1 + lymphocytes, a number quite similar to the percentage of NKHI+T3 + cells. It is thus likely that many NKHI+T3 + lymphocytes also coexpress T8 antigen. In this regard, it should be noted that almost all NK-active clones that express both NKH1 and T3 also coexpress T8 antigen. NKHI+Tt 1 + lymphocytes make up 9.6% of total PBMC. Unlike other T cellassociated antigens, T 11 + cells represent the great majority of the NKH 1 + subset.
Purification ofNKHI+T3 + Cells. After showing the presence of NKHI+T3 + lymphocytes in peripheral blood, we used immunofluorescent cell sorting to the typical structural appearance of LGL, whereas NKH1-T3 + cells (C) show the characteristics of small T lymphocytes.
NK Activity ofNKHI+T3 + Lymphocytes. When tested against K562 target cells,
purified NKH l+T3 + cells mediate cytotoxicity at relatively low E/T ratios (Fig.  3A) . For comparison, there was some ~hat higher activity in the NKHI+T3 -population, but no cytotoxicity was mediated by NKH l-T3 + cells. Similar results were seen in four of five different experiments, but in one experiment, both NKHI+T3 + and NKH l+T3 -populations exhibited equivalent levels of cytotoxicity. Also shown in Fig. 3A , addition of monoclonal anti-T3 can completely abrogate the NK activity of NKHI+T3 + cells. In control experiments, anti-T3 did not abrogate NK activity on NKH 1 +T3-cells and anti-NKH 1A did not inhibit cytotoxicity of either NKH 1 +T3 + or NKH 1 +T3-cells (data not shown). The effect of anti-T3 was also evaluated with NKHI+T3 + lymphocytes that had been cultured in vitro for 14 d. After culture, cells were re-sorted to ensure the purity of the effector cell population before assessment of cytotoxicity. As shown in Fig. 3 B, cultured NKH 1 +T3 + cells display a high degree of cytotoxicity against K562 targets. Addition of anti-NKH 1A does not inhibit cytolytic activity, but incubation with anti-T3 results in marked inhibition. Addition of either anti-T8 or anti-Ia mAbs has no effect on cytotoxicity of NKHI+T3 + cells (data not shown).
Discussion
After purification of NKHI+T3 + cells, we showed that this subset displays spontaneous cytotoxicity as well as the characteristic LGL morphology of NKactive cells. Comparing NKH1 +T3-and NKH 1 +T3 ÷ cells, both exhibit typical LGL morphology, but in some individuals, azurophilic granules appear more pronounced in the NKH l+T3 -subset. This finding is consistent with results of functional assays, since NKHI+T3 -cells display somewhat higher spontaneous cytotoxicity than NKH 1 +T3 + cells. Nevertheless, both NKH 1 + fractions maintain high levels of NK activity compared with NKH1-T3 + cells, which do not kill K562 targets.
Since T3 antigen is noncovalently associated with the T cell receptor for antigen (Ti), and is required for surface membrane expression of Ti-like structures, we used anti-T3 antibody to determine whether NKHI+T3 + NK cells were functionally related to T cells. As described previously for T3 + NK clones (6), cytotoxicity of NKHI+T3 ÷ NK ceils could be blocked by anti-T3. Since incubation with anti-T3 results in comodulation of both T3 and Ti these results suggest that T3+NKH1 + cells use a T cell receptor-like structure to interact with specific targets. These results were confirmed when purified NKHI+T3 ÷ cells were cultured for 14 d, re-sorted, and then tested for NK activity. Cultured ceils maintained a high degree of cytolytic activity, which could be inhibited by anti-T3 but not by antibodies specific for NKH 1, T8, or Ia antigens.
Although the majority of NK cells do not express T3, there have been previous indications that a subset of NK cells is functionally related to T lymphocytes. In particular, recent studies of both human and murine NK clones have shown that some clones have a mature T cell phenotype, express clonotypic receptors for antigen, and have functional rearrangement and expression of T cell receptor genes (6, 9, 10) . Although the analysis of cultured T3 + NK clones may reflect some degree of in vitro selection of cells with a complete T cell phenotype, we have recently shown that clonotypic antigens of NK clones can also be found in low frequency in uncultured peripheral blood (11) . Lymphokine activated killer (LAK) cells, may also represent an expansion of this population of cells. LAK cells have been shown to express a T cell phenotype after in vitro culture (12) , and the majority also express NKH 1.
Although some NK clones appear to have functional characteristics of mature T cells, the majority of NK clones do not express T3 antigen or T cell receptors for antigen, and do not have functional rearrangements of T cell receptor genes (9) . Similarly the majority of NK cells in peripheral blood do not express T3 and do not appear to use T cell-like receptors for target antigen (5). NKHI+T3 + NK cells therefore appear to be a unique and functionally distinct population of NK cells, which can be distinguished from cytotoxic T cells as they can kill a variety of targets in an MHC-independent fashion. However, despite their broad reactivity, the present studies also suggest that this subset of NK cells can mediate their functional activity through a T cell receptor-like structure.
Summary
Normal human PBMC were analyzed for the presence of ceils expressing both T3 and NKH1 antigens, using direct two-color immunofluorescence. In six individuals, NKH l+T3 + cells were found to represent 2.5% of PBMC and 24% of the total number of NKH1 + cells. Purified NKHI+T3 + ceils were shown to have the typical morphology of large granular lymphocytes (LGL). NKHI+T3 + cells also exhibited spontaneous cytotoxicity against K562 target cells and this lytic activity could be inhibited by anti-T3 mAb. Similar results were obtained with NKHI+T3 + cells cultured in vitro in lymphocyte-conditioned medium.
Taken together, these results indicate that NKH l+T3 + cells represent a unique population of NK-active cells in normal peripheral blood. Although these cells exhibit LGL morphology and NK activity, this appears to be mediated through a functional T cell-like receptor for target antigen.
